Hepatitis D

Common Name(s)

Hepatitis D

Hepatitis D is a viral hepatitis that affects the liver and is caused by the hepatitis D virus, or HDV. HDV can only infect people who have hepatitis B, but it is important to remember that not all people with hepatitis B will know they have the condition because they may not have symptoms. An infection with HDV makes the symptoms of hepatitis B worse and increases liver damage. Symptoms may include sudden fever, extreme tiredness, nausea, lack of appetite, stomach pain, and jaundice (yellowing of the skin). HDV does not always cause symptoms. Most people infected with HDV recover within a month. About 10% of people infected with HDV develop a chronic infection. Chronic HDV infection may cause chronic active hepatitis leading to permanent liver scarring (cirrhosis) and liver failure. HDV is spread through contact with infected blood. Common ways of to become infected with HDV include sharing of infected needles, having sexual contact with a person infected by HDV, and from mother to child during childbirth if the mother is infected with HDV. Hepatitis D is diagnosed through blood tests and possibly a liver biopsy.

A vaccine is available to prevent HBV infection which there also will prevent HDV infection. If the condition becomes chronic, there are treatments available to help slow the damage to the liver but there is no cure at this time. HDV infections are diagnosed through blood tests and possibly liver biopsies. Talk with your doctor if you or a family member has been diagnosed with hepatitis D. Support groups are also good resources of support and information. See also Hepatitis B.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatitis D" for support, advocacy or research.

Hepatitis Foundation International

Hepatitis Foundation International is dedicated to promoting wellness and healthy lifestyles for all individuals in order to reduce the incidence of preventable diseases that affect the liver’s health including: obesity, diabetes, fatty liver, high cholesterol, cardiovascular disease, hepatitis, HIV/AIDS, and substance abuse. We inform, educate, and empower by making available reliable and up-to-date information.

Last Updated: 23 Feb 2015

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatitis D" for support, advocacy or research.

Hepatitis Foundation International

Hepatitis Foundation International is dedicated to promoting wellness and healthy lifestyles for all individuals in order to reduce the incidence of preventable diseases that affect the liver’s health including: obesity, diabetes, fatty liver, high cholesterol, cardiovascular disease, hepatitis, HIV/AIDS, and substance abuse. We inform, educate, and empower by making available reliable and up-to-date information.

http://www.HepatitisFoundation.org

Last Updated: 23 Feb 2015

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatitis D" returned 165 free, full-text research articles on human participants. First 3 results:

Is there an association between vitamin D and liver fibrosis in patients with chronic hepatitis C?
 

Author(s): Kalinca da Silva Oliveira, Caroline Buss, Cristiane Valle Tovo

Journal: Arq Gastroenterol. ;54(1):57-59.

 

- Vitamin D is known for its immunomodulatory, anti-inflammatory and antifibrotic properties, which are quite relevant in the pathogenesis and treatment of many causes of chronic liver disease.

Last Updated: 12 Jan 2017

Go To URL
A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
 

Author(s): Marie Atsama Amougou, Dominique Noah Noah, Paul Fewou Moundipa, Pascal Pineau, Richard Njouom

Journal:

 

Hepatocellular Carcinoma (HCC) is one of the commonest cancers in Central Africa, a region with the unusual peculiarity to be hyperendemic for infections with Hepatitis B, C and D viruses. However, data estimating the respective proportions of HCC cases attributable to these viruses ...

Last Updated: 8 Nov 2016

Go To URL
Presence of acute hepatitis D infection in HBsAg positive cancer patients: A preliminary study from west Gujarat.
 

Author(s): Foram Maulin Patel, Parijath N Goswami

Journal: Indian J. Med. Res.. 2016 Jun;143(6):798-800.

 

Hepatitis delta virus (HDV) and hepatitis B virus (HBV) co-infection is well known to induce a spectrum of acute and chronic liver diseases. There has been global decline in the prevalence of hepatitis D infection. The aim of the present study was to know the presence of acute HDV ...

Last Updated: 17 Oct 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatitis D" returned 16 free, full-text review articles on human participants. First 3 results:

Hepatitis D virus infection in Slovenian patients with chronic hepatitis B virus infection: a national prevalence study and literature review.
 

Author(s): Mateja M Jelen, Lea Hošnjak, Špela Štunf, Anja Zagožen, Kristina Fujs Komloš, Petra Markočič, Mario Poljak, Katja Seme

Journal: Acta Dermatovenerol Alp Pannonica Adriat. 2016 Sep;25(3):49-53.

 

Of the 350 million individuals chronically infected with hepatitis B virus (HBV) worldwide, approximately 15 to 20 million have been exposed to hepatitis D virus (HDV). This study determined for the first time the HDV prevalence in Slovenian patients with chronic HBV infection. In ...

Last Updated: 3 Oct 2016

Go To URL
Hepatitis D virus coinfection and superinfection.
 

Author(s): Francesco Negro

Journal:

 

HDV is a defective RNA pathogen requiring the simultaneous presence of HBV to complete its life cycle. Two major specific patterns of infection have been described: the coinfection with HDV and HBV of a susceptible, anti-HBs-negative individual, or the HDV superinfection of a chronic ...

Last Updated: 4 Nov 2014

Go To URL
Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis.
 

Author(s): Yue-qiu Luo, Xiao-xing Wu, Zong-xin Ling, Yi-wen Cheng, Li Yuan, Charlie Xiang

Journal: J Zhejiang Univ Sci B. 2014 Oct;15(10):900-6.

 

To conduct a systematic review of group studies assessing the association of serum vitamin D status with the severity of liver fibrosis in chronic hepatitis C patients using meta-analysis. The relevant research literatures were identified by searching PubMed and EMBASE databases prior ...

Last Updated: 8 Oct 2014

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Ezetimibe for Patients With Chronic Hepatitis D
 

Status: Recruiting

Condition Summary: Chronic Hepatitis D

 

Last Updated: 28 Mar 2017

Go to URL
The Hepatitis Delta International Network
 

Status: Recruiting

Condition Summary: Hepatitis D

 

Last Updated: 26 Aug 2015

Go to URL

Last Updated: 31 May 2017

Go to URL